Keywords: Contrast Agents, Neurography, USPIO, Lymph Node
Motivation: Ferumoxytol provides vascular suppression in magnetic resonance neurography (MRN), but its effectiveness for lymph node suppression in MRN has not been quantified.
Goal(s): To determine the optimal time and extent of lymph suppression achievable with a low-dose Ferumoxytol infusion for MRN.
Approach: Two healthy subjects were imaged over a 50-hour post-infusion interval to determine the optimal time for MRN. Eight subjects were imaged to quantify lymph node suppression at the optimal time.
Results: Immediately post-infusion (<1 hour), no significant differences were observed between nerve-to-muscle and lymph node-to-muscle contrast ratios. However, at the optimal 15 hours post-infusion, lymph node-to-muscle contrast ratios were significantly reduced.
Impact: Low-dose Ferumoxytol provides significant lymph node suppression and simultaneous vascular suppression in brachial plexus magnetic resonance neurography (MRN) 15 hours post-infusion. Lymph suppression may enable 3D rendering to improve nerve visualization in diagnostic and surgical planning applications.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords